Viridian (NASDAQ: VRDN) CMO acquires 40K shares via option
Rhea-AI Filing Summary
Viridian Therapeutics, Inc. (VRDN) reported that its Chief Medical Officer, Radhika Tripuraneni, exercised a stock option for 40,000 shares of common stock on 2026-08-14 at an exercise price of $13.21 per share. The exercised option, which was fully vested, now shows 0 derivative shares remaining, and her directly held common stock position increased to 40,000 shares following the transaction.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 40,000 shares
Net Buy
2 txns
Insider
Tripuraneni Radhika
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 40,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 40,000 | $13.21 | $528K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 40,000 shares (Direct)
Footnotes (1)
- F1. The option is fully vested.
Key Figures
Option shares exercised: 40,000 shares
Exercise price: $13.21 per share
Common shares acquired: 40,000 shares
+2 more
5 metrics
Option shares exercised
40,000 shares
Stock Option (Right to Buy) exercised on 2026-08-14
Exercise price
$13.21 per share
Exercise price of stock option for 40,000 underlying common shares
Common shares acquired
40,000 shares
Common stock position reported following the option exercise
Derivative shares remaining
0 shares
Stock Option (Right to Buy) after full exercise
Option expiration date
2034-07-01
Expiration date of the exercised stock option grant
Key Terms
Stock Option (Right to Buy), derivative security, exercise price
3 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise price financial
"conversion_or_exercise_price: 13.2100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transaction did VRDN Chief Medical Officer Radhika Tripuraneni report?
Radhika Tripuraneni reported exercising a stock option for 40,000 shares of Viridian Therapeutics common stock at an exercise price of $13.21 per share on 2026-08-14. This converted her option position into directly held common shares.
What was the exercise price of the Viridian Therapeutics (VRDN) stock option exercised?
The stock option was exercised at $13.21 per share for 40,000 underlying common shares. This exercise converted the option, which was fully vested, into an equivalent number of directly owned common shares.
When does the exercised Viridian Therapeutics (VRDN) stock option expire?
The exercised stock option had an expiration date of 2034-07-01. It was already fully vested at the time of the 2026-08-14 exercise, as disclosed in the footnote to the derivative transaction.
Was the VRDN Form 4 transaction under a Rule 10b5-1 trading plan?
The document-level Rule 10b5-1 checkbox is not marked as true, and no footnote states that the option exercise occurred under a Rule 10b5-1 trading plan, based on the reported data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
